We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Dissemination of a Localized Cutaneous Infection With Mycobacterium chelonae Under Immunosuppressive Treatment

Wolfram Hoetzenecker, MD, PhD; Anja Ulmer, MD; Karin Klingel, PhD; Volkhard A. J. Kempf, MD; Stefan Schanz, MD; Gisela Metzler, MD; Gerhard Fierlbeck, MD
Arch Dermatol. 2007;143(7):945-955. doi:10.1001/archderm.143.7.951.
Text Size: A A A
Published online


We report a case of an initially localized cutaneous infection with Mycobacterium chelonae on the left breast. Owing to the failure to recognize the causative agent, high-dose immunosuppressive treatment was administered for 2 years. As a result, infection disseminated with the development of multiple ulcerating and fistulating nodules on the right leg.

Popper  HHKlemen  HHoefler  GWinter  E Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997;28 (7) 796- 800
PubMed Link to Article[[XSLOpenURL/10.1016/S0046-8177(97)90152-0]]
Kyle  SDPorter  WM Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid. Br J Dermatol 2004;151 (5) 1101
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2004.151.issue-5]]
Brown-Elliott  BAWallace  RJBlinkhorn  RCrist  CJMann  LB Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001;33 (8) 1433- 1434
PubMed Link to Article[[XSLOpenURL/10.1086/cid.2001.33.issue-8]]
Levine  NRothschild  JG Treatment of Mycobacterium chelonae infection with controlled localized heating. J Am Acad Dermatol 1991;24 (5, pt 2) 867- 870
PubMed Link to Article[[XSLOpenURL/10.1016/0190-9622(91)70135-O]]
Franck  NCabie  AVillette  B  et al.  Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol 1993;28 (6) 1019- 1021
PubMed Link to Article[[XSLOpenURL/10.1016/S0190-9622(08)80660-3]]
Wallace  RJ  JrBrown  BAOnyi  GO Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992;166 (2) 405- 412
PubMed Link to Article[[XSLOpenURL/10.1093/infdis/166.2.405]]
Uslan  DZKowalski  TJWengenack  NLVirk  AWilson  JW Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 2006;142 (10) 1287- 1292
Vemulapalli  RKCantey  JRSteed  LLKnapp  TLThielman  NM Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. J Infect 2001;43 (3) 163- 168
PubMed Link to Article[[XSLOpenURL/10.1053/jinf.2001.0880]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Disseminated cutaneous infection with Mycobacterium chelonae after long-term immunosuppressive treatment. A and B, Multiple, fistulating nodules with surrounding erythema on the right leg; B, inset, pyoderma gangrenosum–like aspect of M chelonae–infected ulcer. C and D, Clinical appearance after 9 months of antibiotic treatment.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

5 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles